Technical Analysis for AVCT - Avacta Group Plc
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 49.75 | 1.53% | 0.75 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Very Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Low | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | 1.53% | |
New 52 Week Low | Weakness | 1.53% | |
Multiple of Ten Bearish | Other | 1.53% | |
Lower Bollinger Band Touch | Weakness | 1.53% | |
Oversold Stochastic | Weakness | 1.53% | |
Wide Bands | Range Expansion | -2.26% | |
Oversold Stochastic | Weakness | -2.26% |
Alert | Time |
---|---|
Up 2% | about 16 hours ago |
Lower Bollinger Band Support | about 17 hours ago |
Up 1% | about 17 hours ago |
2x Volume Pace | about 21 hours ago |
1.5x Volume Pace | about 21 hours ago |
Get a Trading Sidekick!
Avacta Group Plc Description
Avacta Group plc is a biotechnology company. Avacta's focus is on its proprietary Affimer technology which is an engineered alternative to antibodies that has application in Life Sciences for diagnostics, therapeutics and general research and development. Affimer technology has been designed to address performance limitations of antibodies. Affimer technology is based on a small protein that can be generated to bind with specificity and affinity to a range of targets to enable diagnostics, research assays and therapeutics. Avacta has a pre-clinical therapeutic development programme with an in-house focus on immuno-oncology and bleeding disorders as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Biotechnology Medicine Science Life Sciences Tools Branches Of Biology Medical Specialties Clinic Oncology Antibodies Immunology Disorders Immune System Assay Aptamer Synthetic Antibody
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 166.98 |
52 Week Low | 47.325 |
Average Volume | 2,723,376 |
200-Day Moving Average | 108.30 |
50-Day Moving Average | 78.18 |
20-Day Moving Average | 52.83 |
10-Day Moving Average | 51.14 |
Average True Range | 3.96 |
RSI (14) | 26.47 |
ADX | 54.48 |
+DI | 10.61 |
-DI | 34.50 |
Chandelier Exit (Long, 3 ATRs) | 66.86 |
Chandelier Exit (Short, 3 ATRs) | 59.21 |
Upper Bollinger Bands | 57.45 |
Lower Bollinger Band | 48.21 |
Percent B (%b) | 0.17 |
BandWidth | 17.50 |
MACD Line | -7.99 |
MACD Signal Line | -9.32 |
MACD Histogram | 1.3245 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 53.76 | ||||
Resistance 3 (R3) | 53.40 | 51.70 | 53.09 | ||
Resistance 2 (R2) | 51.70 | 50.68 | 51.88 | 52.87 | |
Resistance 1 (R1) | 50.73 | 50.05 | 51.21 | 51.09 | 52.65 |
Pivot Point | 49.03 | 49.03 | 49.27 | 49.21 | 49.03 |
Support 1 (S1) | 48.05 | 48.00 | 48.54 | 48.41 | 46.85 |
Support 2 (S2) | 46.35 | 47.37 | 46.53 | 46.63 | |
Support 3 (S3) | 45.38 | 46.35 | 46.41 | ||
Support 4 (S4) | 45.74 |